Advocacy Committee
The Advocacy Committee meets on an as-needed basis to develop the extent and the manner in which CIS pursues actions to influence government policy at the state and federal level.
Chair
Monica G. Lawrence, MD - University of Virginia
Members
Diana K. Bayer, DO - University of Iowa Carver College of Medicine
Joud Hajjar, MD, PhD, MS, FCIS - Baylor College of Medicine
Yasmin W. Khan, MD - Vanderbuilt University Medical Center
Niraj C. Patel, MD, MS - Duke University
Michele N. Pham, MD - University of California, San Francisco
Nikita Raje, MD, MSc - Children's Mercy Hospital
Joyce E. Yu, MD - Columbia University Irving Medical Center
Continuing Medical Education (CME) Committee
The Continuing Medical Education (CME) Committee is responsible for review and oversight of CME activity planning, interaction with planners and speakers, content development and review, and the management of commercial support for all directly and jointly sponsored CME activities in addition to oversight of the ACCME re-accreditation process every four years. This committee meets approximately four times per year via conference call.
Chair
Manar Abdalgani, MD - Columbia University
Members
George E. Freigeh, MD, MA - University of Michigan
Joud Hajjar, MD, PhD, MS, FCIS - Baylor College of Medicine
Ciang Sang Tan, MD - Hospital Pengajar Universiti Putra Malaysia
Diagnostic Laboratory Immunology (DLI) Committee
The mission of the Diagnostic Laboratory Immunology Committee will be to create, promote and curate all matters relevant to DLI in its contribution to the overall mission of the CIS (to facilitate education, translational research and novel approaches to therapy in clinical immunology to promote excellence in the care of patients with immunologic/inflammatory disorders).
Chair
James Verbsky, MD, PhD, FCIS - Medical College of Wisconsin
Members
Jordan Abbott, MD - Children's Hospital Colorado
Neema Izadi, MD, MS - Children's Hospital Los Angeles / USC Keck School of Medicine
Stanley J. Naides, MD - Laboratory Corporation of America
Xiao P. Peng, MD, PhD - Johns Hopkins University
Teresa K. Tarrant, MD - Duke University
Russell H. Tomar, MD
Diversity & Inclusion (D&I) Committee
The purpose of this committee is to promote and enhance diversity, equity, and inclusion within the Clinical Immunology Society and within the broader fields of Clinical, Translational, and Investigational Immunology. The committee will focus on education, advocacy, mentorship and other efforts to expand the diversity of voices and opinions within our vibrant and exciting field. This will build on the successes and groundwork laid by the Women in Clinical Immunology Society (WCIS) committee and WCIS will become a standing subcommittee within the Diversity and Inclusion Committee. The Committee will encourage and help facilitate diversity within CIS leadership, committee membership, speakers at webinars and educational activities, and annual meeting sessions. Additionally, the Committee will provide input to the CIS Executive Council regarding diversity and inclusion in the CIS Strategic Plan and will work with the Council to carry out these elements of the Plan.
Co-Chairs
Art M. Jongco III, MPH, MD, PhD - Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Jennifer Leiding, MD, FCIS - Johns Hopkins University
Members
Aisha Ahmed, MD - Lurie Children's Hospital
Hey J. Chong, MD, PhD - University of Pittsburgh Children's Hospital
Antonio Condino-Neto, FCIS - University of Sao Paulo
Blachy J. Davila-Saldana, MD - Children's National Medical Center
George E. Freigeh, MD, MA - University of Michigan
Sarah E. Henrickson, MD, PhD - The Children's Hospital of Philadelphia
Vivian P. Hernandez-Trujillo, MD - Allergy and Immunology Care Center of South Florida
Gabriel Mendoza - University of Washington and Seattle Children's Hospital
Lauren A. Sanchez, MD - University of California San Francisco
Andrew L. Snow, PhD, FCIS - Uniformed Services University of the Health Sciences
Sneha Suresh, MD - University of Alberta
WCIS is a subcommittee within the Diversity and Inclusion Committee. The goal of the WCIS Committee is to support and encourage the advancement of women at all levels (general members, students, residents, fellows, post-doctoral, clinicians, and faculty) in the CIS to attain their full academic potential via mentorship, sponsorship, personal and professional development, leadership, innovation, inclusiveness, and a welcoming and supportive climate.
Chair
Sarah E. Henrickson, MD, PhD - The Children's Hospital of Philadelphia
Members
Hanadys Ale, MD - Joe DiMaggio Children's Hospital
Diana K. Bayer, DO - University of Iowa Carver College of Medicine
Taya Carpenter - Westchester Medical Center
Helene Decaluwe, MD, PhD, FRCPC, FCIS - University of Montreal, Saint-Justine Hospital
Monica Fernandes - Universidad Del Valle
Alexandra F. Freeman, MD, FCIS - NIH NIAID
Catherine Freeman - Mayo Clinic Arizona
Jessica Galant-Swafford - National Jewish Health
Lauren M. Gunderman, MD - Ann & Robert H. Lurie Children's Hospital of Chicago
Joud Hajjar, MD, PhD, MS, FCIS - Baylor College of Medicine
Vivian P. Hernandez-Trujillo, MD - Allergy and Immunology Care Center of South Florida
Vy Kim, MD, MScCH, FRCPC, FCIS - Hospital for Sick Children
Madeline M. Schutt, MD - Ann & Robert Lurie Children's Hospital of Chicago
Early Career Immunologists (ECI) Committee
The Early Career Immunologists (ECI) Committee is responsible for developing and overseeing benefits and programs for current and future Trainee Members and junior faculty members. The ECI Committee will meet regularly via conference call and will work with other committees such as the Education, Program, and Membership Committees throughout the year to assist with CIS communications and Annual Meeting planning targeted to Trainee Members and junior faculty members as well as membership recruitment.
Co-Chairs
Carolyn H. Baloh, MD - Brigham & Women's Hospital
Natalia S. Chaimowitz, MD, PhD - Cook Children's Hospital
Members
Hanadys Ale, MD - Joe DiMaggio Children's Hospital
Christin Deal, MD - University of Pittsburgh Medical Center
Melissa D. Gans, MD - University of Miami
Harry Lesmana - Cleveland Clinic
Joao P. Matias Lopes - UH Rainbow Babies and Children/Case Western Reserve University
Erica G. Schmitt, MD, PhD - Washington University St. Louis
Junghee J. Shin, MD, PhD - Yale University
Jacqueline D. Squire, MD - Mayo Clinic Jacksonville
Monica Tang - Univeristy of California
Juanita Valdes Camacho, MD - Louisiana State University Shreveport
Education Committee
The Education Committee will work to develop and implement educational activities that would be of interest to members including, but not limited to, webinars, podcasts, videos, and various live activities. The committee will also provide members with current information on available educational opportunities within the society, and initiate and implement educational policies.
Chair
David Hagin, MD, PhD, FCIS - Tel-Aviv Sourasky Medical Center
Members
Eric J. Allenspach, MD, PhD - University of Washington & Seattle Children's Hospital
Shanmuganathan Chandrakasan, MD, FCIS - Emory University School of Medicine
Karin Chen, MD - University of Washington & Seattle Children's Hospital
Nicholas L. Hartog, MD - Helen DeVos Children's Hospital
Jennifer Heimall, MD, FCIS - The Children's Hospital of Philadelphia
Edith Schussler, MD - Weil Cornell Medicine
Gesmar R. Silva Segundo, MD, PhD - Federal University of Uberlandia
Troy R. Torgerson, MD, PhD, FCIS - Allen Institute for Immunology
Elizabeth Varga, MS - Nationwide Children's Hospital
Donald C. Vinh, MD, FCIS - McGill University Health Centre
Nicola Wright, MD, FCIS - Alberta Children's Hospital
Fellows in CIS (FCIS) Committee
The purpose of the CIS Fellowship Committee is to serve as an oversight body to review the eligibility of applicants seeking the FCIS designation. Current Fellows in good standing will recommend future Fellows.
Co-Chairs
Mark Ballow, MD, FAAAAI , FCIS - University of South Florida
Charlotte Cunningham-Rundles, MD, PhD, FCIS - Mt. Sinai Medical Center
Members
Roshini S. Abraham, PhD, D(ABMLI) FCIS - Nationwide Children's Hospital
Thomas A. Fleisher, MD, FCIS - NIH Clinical Center
Sudhir Gupta, MD, PhD, MACP, FAAAAI, FCIS - University of California, Irvine
Rebecca A. Marsh, MD, FCIS - Cincinnati Children's Hospital Medical Center
John M. Routes, MD, FCIS - Medical College of Wisconsin
Stuart Turvey, MBBS, DPhil, FRCPC, FCIS - University of British Columbia
Foundation Committee
The CIS Foundation Committee was created to support the CIS Foundation with its fundraising which will advance research and education among CIS members and the larger patient and donor community. Learn more about the CIS Foundation.
Chair
Kelli W. Williams, MD, MPH, FCIS - Medical University of South Carolina
Members
Daniel C. Adelman, MD, FCIS - University of California, San Francisco
Victoria R. Dimitriades, MD - University of California Davis Health
Lisa R. Forbes Satter, MD - Baylor College of Medicine
Alexandra F. Freeman, MD, FCIS - NIH NIADID
Monica G. Lawrence, MD - University of Virginia
Niraj C. Patel, MD, MS - Duke University
Troy R. Torgerson, MD, PhD, FCIS - Allen Institute for Immunology
Investigators of CIS (I-CIS) Committee
The Investigators of CIS Committee works to build a community of basic, translational and clinical investigators to advance the discovery and treatment of inborn errors of immunity. They do so by providing a framework for educational programming and activities specific to the needs of investigators and advocating for funding and other support for the career development of clinical immunology investigators.
Co-Chairs
Megan A. Cooper, MD, PhD, FCIS - Washington University
Lisa R. Forbes Satter, MD - Baylor College of Medicine
Members
Elie Haddad, MD, PhD, FCIS - CHU Ste-Justine, University of Montreal
Elena W. Hsieh, MD - University of Colorado Denver
Membership Committee
The Membership Committee shall review the applications for eligibility on the basis of criteria approved by the Council including good moral and ethical character. The Membership Committee meets to approve members and discuss business approximately four to six times a year.
Chair
Jenna R. Bergerson, MD - NIH, NIAID/LCIM
Members
Aisha Ahmed, MD - Lurie Children's Hospital
Luis E. Murguia-Favela, MD, FRCPC, FCIS - University of Calgary
Maria C. Poli, MD, PhD - Universidad del Desarrollo
Ismail Reisli, MD - Necmettin Erbakan University
Katherine L. Tuttle, MD - University of Rochester
Program Committee (2024 Annual Meeting)
The Program Committee develops the programming and abstract selection for the Annual Meeting, along with fundraising efforts and may be asked to moderate interactive discussions generated from the presentations. The committee meets via conference call approximately six times during the program development.
Co-Chairs
Elie Haddad, MD, PhD, FCIS - CHU Ste-Justine, University of Montreal
Emily Mace, PhD - Colombia University
Luigi D. Notarangelo, MD, FCIS - NIAID-NIH
Members
Maria Cecilia Poli, MD, PhD - Universidad del Desarollo
Despina Moshous - Institut Imagine Necker University Children's Hospital
Dusan Bogunovic, PhD - Icahn School of Medicine at Mount Sinai
Elena Wy Hsieh, MD - University of Colorado Denver
Eric J. Allenspach, MD, PhD - University of Washington & Seattle Children's Hospital
Ivona Aksentijevich, MD, FCIS - Human Genome Research Institute
Raz Somech, MD, PhD - Edmond and Lilu Safra Children's Hospital
Stuart Turvey, MBBS, DPhil, FRCPC, FCIS - University of British Columbia
Christen L. Ebens, MD, MPH - University of Minnesota
Thymic Defect Taskforce (TDT)
The Thymic Defect Taskforce's (TDT) mission is to address the growing need in the field of Clinical Immunology and Primary Immunodeficiencies of the role of thymus transplantation in the management of patients with thymic defects. The objectives of the taskforce would be to develop guidelines, on behalf of CIS that would outline the biology of thymic defects, the gaps in clinical care, current management strategies, need and access issues in thymus transplantation, protocols of thymus transplantation and monitoring, regulatory issues and future directions. The TDT will also endeavor to collaborate with existing registries to expand an existing, or add a new registry for patients diagnosed with thymic defects, especially via newborn screening.
Chair
Elie Haddad, MD, PhD - CHU Ste-Justine, University of Montreal
Members
Luigi D. Notarangelo, MD, FCIS - NIAID-NIH
Troy R. Torgerson, MD, PhD, FCIS - Allen Institute for Immunology
Jack J. Bleesing, MD, PhD, FCIS - Cincinnati Children's Hospital
Rebecca A. Marsh, MD, FCIS - Cincinnati Children's Hospital Medical Center
Cathleen Collins, MD, PhD - UCSD
Michael D. Keller, MD, FCIS - Children's National Hospital
Vivian P. Hernandez-Trujillo, MD - Allergy and Immunology Care Center of South Florida
Ivan K. Chinn, MD, FCIS - Baylor College of Medicine
E. Graham Davies - Great Ormond Street Hospital
M. Teresa De La Morena, MD, FCIS - Seattle Children's Hospital/University of Washington
Michail S. Lionakis, MD - NIH
Peter Mustillo, MD - Nationwide Children's Hospital
Marita Bosticardo, PhD - National Institutes of Health
Prescott Atkinson, MD, PhD, FAAAAI - University of Alabama at Birmingham/Children's Hospital
Elisa Ochfeld, MD - Children's Hospital Of Philadelphia
Daniel C. Adelman, MD, FCIS - University of California, San Francisco
Alexandra Y. Kreins - Great Ormond Street Hospital/UCL